Cannabisin B

Cannabisin B
Product Name Cannabisin B
CAS No.: 144506-17-2
Catalog No.: CFN95268
Molecular Formula: C34H32N2O8
Molecular Weight: 596.6 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Targets: Akt | mTOR
Source: The herbs of Cannabis sativa L.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $413/5mg
Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Med Food.2024, 27(8):728-739.
  • Molecules.2019, 24(23):E4303
  • Sci Rep.2018, 8:9267
  • J of the Society of Cosmetic Scientists of Korea2018, 44(4):407-417
  • Life Sci.2023, 332:122107.
  • Molecules.2017, 22(11)
  • Journal of Mushroom2024, 22(4):192-198
  • Front Immunol. 2020, 11:62.
  • Int J Mol Sci.2020, 21(22):8816.
  • Biomed Pharmacother.2022, 146:112497.
  • Lyciumamide B

    Catalog No: CFN95286
    CAS No: 1647111-41-8
    Price: $318/5mg
    Cannabisin H

    Catalog No: CFN94001
    CAS No: 403647-08-5
    Price: $390/5mg
    Kukoamine A

    Catalog No: CFN93215
    CAS No: 75288-96-9
    Price: Inquiry(manager@chemfaces.com)
    Kukoamine B

    Catalog No: CFN93216
    CAS No: 164991-67-7
    Price: $268/10mg
    Asperglaucide

    Catalog No: CFN98937
    CAS No: 56121-42-7
    Price: $238/5mg
    Aurantiamide

    Catalog No: CFN98984
    CAS No: 58115-31-4
    Price: $218/5mg
    Aurantiamide benzoate

    Catalog No: CFN91929
    CAS No: 150881-02-0
    Price: Inquiry(manager@chemfaces.com)
    Auranamide

    Catalog No: CFN95804
    CAS No: 740813-53-0
    Price: $413/5mg
    Cannabisin B

    Catalog No: CFN95268
    CAS No: 144506-17-2
    Price: $413/5mg
    Cannabisin D

    Catalog No: CFN90405
    CAS No: 144506-19-4
    Price: $488/5 mg
    Food Chemistry, 2013,138(2-3):1034-41.
    Cannabisin B induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cells.[Reference: WebLink]

    METHODS AND RESULTS:
    This study investigates the anticancer properties of Cannabisin B, purified from hempseed hull, in HepG2 human hepatoblastoma cells. The results indicate that Cannabisin B significantly inhibited cell proliferation by inducing autophagic cell death rather than typical apoptosis. Cell viability transiently increased upon the addition of a low concentration of Cannabisin B but decreased upon the addition of high concentrations. Cannabisin B-induced changes in cell viability were completely inhibited by pre-treatment with 3-methyladenine (3-MA), indicating that the induction of autophagy by Cannabisin B caused cell death. Additionally, Cannabisin B induced S phase cell cycle arrest in a dose-dependent manner. Moreover, Cannabisin B was found to inhibit survival signaling by blocking the activation of AKT and down-stream targets of the mammalian target of rapamycin (mTOR).
    CONCLUSIONS:
    These findings suggest that Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease.
    Lucidumol A

    Catalog No: CFN95059
    CAS No: 217476-73-8
    Price: $318/5mg
    Lappaol C

    Catalog No: CFN95068
    CAS No: 64855-00-1
    Price: $333/10mg
    Bidenoside C

    Catalog No: CFN95266
    CAS No: 700877-55-0
    Price: $318/5mg
    Arganine B

    Catalog No: CFN95281
    CAS No: 144425-21-8
    Price: $318/5mg
    1-(3',5'-dimethoxy)phenyl-2-[4''-O-beta-D-glucopyranosyl (6->1)-O-alpha-L-rhamnopyranosyl]phenylethane

    Catalog No: CFN95285
    CAS No: 1338076-61-1
    Price: $413/5mg
    Lariciresinol 4-O-glucoside

    Catalog No: CFN95389
    CAS No: 143663-00-7
    Price: $318/5mg
    4-O-Caffeoyl-3-O-syringoylquinic acid

    Catalog No: CFN95430
    CAS No: 1207645-17-7
    Price: $413/5mg
    10-Methoxygambogenic acid

    Catalog No: CFN95450
    CAS No: 2095102-72-8
    Price: $318/10mg
    Quercetin 3,5-O-diglucoside

    Catalog No: CFN95486
    CAS No: 206257-35-4
    Price: $368/10mg
    Hainanic acid B

    Catalog No: CFN95526
    CAS No: 1637737-46-2
    Price: $413/5mg